About Kapsid
Kapsid is a Healthcare company based in Kolkata (India) founded in 2023 by Raja Karmakar. It provides HPC clusters and expertise for molecular simulations research acceleration. It operates on a B2B model. Its Indian entity Biosymphony Private Limited reported revenue of ₹2.9 Lakh. Kapsid offers products and services including HPC Clusters and Molecular Simulation Tools. Its focus areas include Science and Technology, Biotechnology, Molecular Simulations and Computational Tools. Its competitors include Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Magnitude Biosciences and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Kapsid Simulations offers computational tools and high-performance computing clusters with fast GPUs to universities in India. They focus on molecular simulations for studying protein-ligand interactions, DNA-protein complexes, and lipid-membrane systems to advance scientific discovery. Based in Kolkata, they partner with institutions like IISER Kolkata and the University of Calcutta, providing expertise and support for groundbreaking research projects in related fields.
- Headquarters Kolkata, India
- Founders Raja Karmakar
- SectorsHealthcare
- Email••••••••
- Website kapsid.com
- Social LinkedIn
- Legal Name Biosymphony Private Limited
- Date of Incorporation 26 Oct, 2023
- Jurisdiction Kanchrapara, West Bengal, India
- Annual Revenue₹2.9 Lakh
FY 2025 · +2721% YoY
- Net Loss-₹1.3 Lakh
FY 2025 · -43% margin
- EBITDA₹83,558
FY 2025 · 29% margin
Associated legal entities of Kapsid
Kapsid operates through Biosymphony Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biosymphony Private Limited CIN U72100WB2023PTC265840 | Active | 26 Oct 2023 | Kanchrapara, West Bengal | ₹0.0 Cr | – | 2 | View details |
Products & Services of Kapsid
Kapsid offers a comprehensive portfolio of products and services, including HPC Clusters and Molecular Simulation Tools.
Offers GPU-based clusters for accelerated molecular simulations research
Provides tools for protein-ligand and DNA-protein interaction studies
Board of directors of Biosymphony Private Limited (Kapsid)
Biosymphony Private Limited is the primary company behind Kapsid. The board of Biosymphony Private Limited currently have 2 directors; the longest-serving is Rajani Karmakar, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajani Karmakar DIN 10371441 | Director | 26 Oct 2023 | 2 yrs 11 mo | Biosymphony Private Limited |
| Raja Babu Karmakar DIN 10371442 | Director | 26 Oct 2023 | 2 yrs 11 mo | Biosymphony Private Limited |
People of Kapsid
1 people are tracked at Kapsid (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Kapsid
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Kapsid
Figures of Biosymphony Private Limited, the primary company behind Kapsid, for FY 2025. Revenue was ₹2.9 Lakh (+2721% year on year). Net loss was -₹1.3 Lakh (-43% margin). EBITDA was ₹83,558 (29% margin).
- ₹2.9 LakhRevenue · FY 2025 · +2721% YoY
- -₹1.3 LakhNet loss · -43% margin
- ₹83,558EBITDA · 29% margin
- ₹55,000Paid-up capital
Balance sheet, profit and loss, cash flow and ratios of Biosymphony Private Limited are on its company page.
Detailed financial statements for Kapsid
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Kapsid
Kapsid has 9 listed competitors in our database, 7 of them funded. They include Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Magnitude Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| slingshotbio.com | 2012 | Berkeley, United States | $46.38M | 46 | Next-generation synthetic cells are developed for diagnostics and therapeutics. | |
| stemonix.com | 2014 | San Diego, United States | $33.7M | – | Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products. | |
| interaxbiotech.com | 2016 | Villigen, Switzerland | $3.19M | – | Mutated arrestins are employed as biosensors for GPCR drug discovery. | |
| zobio.com | 2004 | Leiden, Netherlands | – | – | Provider of fragment-based drug discovery services | |
| magnitudebiosciences.com | 2018 | Durham, United Kingdom | $1.95M | 12 | Cell-free in vitro assays are supplied to drug discovery firms. | |
| signalpharm.com | 1993 | San Diego, United States | $12M | – | Small molecule drugs regulating disease-associated genes are developed. | |
| sequencebio.com | 2013 | – | $5.47M | – | Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines. | |
| tagcyx.com | 2007 | Yokohama, Japan | $4.9M | – | Provider of nucleic acid-based drug discovery platform | |
| orphagen.com | 2001 | San Diego, United States | – | 7 | Specialty company focused on translational research, discovering new classes of small molecule drugs |
Detailed competitors of Kapsid
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kapsid
The website of Kapsid (kapsid.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 17.9% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Kapsid (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kapsid
Kapsid was founded in 2023.
Kapsid is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
The primary company behind Kapsid, Biosymphony Private Limited, reported revenue of ₹2.9 Lakh for FY 2025, up 2721% year on year.
Kapsid Simulations offers computational tools and high-performance computing clusters with fast GPUs to universities in India. They focus on molecular simulations for studying protein-ligand interactions, DNA-protein complexes, and lipid-membrane systems to advance scientific discovery. Based in Kolkata, they partner with institutions like IISER Kolkata and the University of Calcutta, providing expertise and support for groundbreaking research projects in related fields.
Kapsid's top competitors include Magnitude Biosciences, Slingshot Bioscience and StemoniX.
Kapsid offers HPC Clusters and Molecular Simulation Tools.
Kapsid operates through Biosymphony Private Limited.
The legal entities of Kapsid currently have 2 directors, including Rajani Karmakar, Raja Babu Karmakar.